vs
安费诺(APH)与TENET HEALTHCARE CORP(THC)财务数据对比。点击上方公司名可切换其他公司
安费诺的季度营收约是TENET HEALTHCARE CORP的1.4倍($7.6B vs $5.5B),安费诺净利率更高(12.4% vs 11.7%,领先0.7%),安费诺同比增速更快(58.4% vs 9.0%),过去两年安费诺的营收复合增速更高(45.3% vs 1.5%)
安费诺是一家总部位于美国的电子零部件制造企业,核心产品涵盖电子连接器、光纤连接器、同轴电缆等各类线缆及互连系统,是全球互连解决方案领域的主流供应商,品牌名称源自其前身American Phenolic Corp的名称缩写组合。
Tenet Healthcare Corporation是总部位于美国达拉斯的营利性跨国医疗服务企业,旗下拥有USPI等多个品牌、子公司、合资企业及合作主体,运营65家医院及超过450个医疗设施,还通过旗下Conifer Health Solutions为各类医疗系统及其他客户提供专业医疗支持服务
APH vs THC — 直观对比
营收规模更大
APH
是对方的1.4倍
$5.5B
营收增速更快
APH
高出49.4%
9.0%
净利率更高
APH
高出0.7%
11.7%
两年增速更快
APH
近两年复合增速
1.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $7.6B | $5.5B |
| 净利润 | $943.3M | $644.0M |
| 毛利率 | 36.7% | — |
| 营业利润率 | 24.0% | 15.4% |
| 净利率 | 12.4% | 11.7% |
| 营收同比 | 58.4% | 9.0% |
| 净利润同比 | 26.8% | 12.6% |
| 每股收益(稀释后) | $0.72 | $4.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
APH
THC
| Q1 26 | $7.6B | — | ||
| Q4 25 | $6.4B | $5.5B | ||
| Q3 25 | $6.2B | $5.3B | ||
| Q2 25 | $5.7B | $5.3B | ||
| Q1 25 | $4.8B | $5.2B | ||
| Q4 24 | $4.3B | $5.1B | ||
| Q3 24 | $4.0B | $5.1B | ||
| Q2 24 | $3.6B | $5.1B |
净利润
APH
THC
| Q1 26 | $943.3M | — | ||
| Q4 25 | $1.2B | $644.0M | ||
| Q3 25 | $1.2B | $579.0M | ||
| Q2 25 | $1.1B | $522.0M | ||
| Q1 25 | $737.8M | $622.0M | ||
| Q4 24 | $746.1M | $572.0M | ||
| Q3 24 | $604.4M | $681.0M | ||
| Q2 24 | $524.8M | $477.0M |
毛利率
APH
THC
| Q1 26 | 36.7% | — | ||
| Q4 25 | 38.2% | — | ||
| Q3 25 | 38.1% | — | ||
| Q2 25 | 36.3% | — | ||
| Q1 25 | 34.2% | — | ||
| Q4 24 | 34.3% | — | ||
| Q3 24 | 33.6% | — | ||
| Q2 24 | 33.6% | — |
营业利润率
APH
THC
| Q1 26 | 24.0% | — | ||
| Q4 25 | 26.8% | 15.4% | ||
| Q3 25 | 27.5% | 16.8% | ||
| Q2 25 | 25.1% | 15.6% | ||
| Q1 25 | 21.3% | 18.1% | ||
| Q4 24 | 22.1% | 16.2% | ||
| Q3 24 | 20.3% | 21.3% | ||
| Q2 24 | 19.4% | 14.9% |
净利率
APH
THC
| Q1 26 | 12.4% | — | ||
| Q4 25 | 18.6% | 11.7% | ||
| Q3 25 | 20.1% | 10.9% | ||
| Q2 25 | 19.3% | 9.9% | ||
| Q1 25 | 15.3% | 11.9% | ||
| Q4 24 | 17.3% | 11.3% | ||
| Q3 24 | 15.0% | 13.3% | ||
| Q2 24 | 14.5% | 9.3% |
每股收益(稀释后)
APH
THC
| Q1 26 | $0.72 | — | ||
| Q4 25 | $0.93 | $4.22 | ||
| Q3 25 | $0.97 | $3.86 | ||
| Q2 25 | $0.86 | $3.14 | ||
| Q1 25 | $0.58 | $4.27 | ||
| Q4 24 | $0.16 | $3.79 | ||
| Q3 24 | $0.48 | $4.89 | ||
| Q2 24 | $0.41 | $2.64 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $4.6B | $2.9B |
| 总债务越低越好 | $18.7B | $13.1B |
| 股东权益账面价值 | $14.1B | $4.2B |
| 总资产 | $42.1B | $29.7B |
| 负债/权益比越低杠杆越低 | 1.33× | 3.10× |
8季度趋势,按日历期对齐
现金及短期投资
APH
THC
| Q1 26 | $4.6B | — | ||
| Q4 25 | $11.4B | $2.9B | ||
| Q3 25 | $3.9B | $3.0B | ||
| Q2 25 | $3.2B | $2.6B | ||
| Q1 25 | $1.7B | $3.0B | ||
| Q4 24 | $3.3B | $3.0B | ||
| Q3 24 | $1.6B | $4.1B | ||
| Q2 24 | $1.3B | $2.9B |
总债务
APH
THC
| Q1 26 | $18.7B | — | ||
| Q4 25 | $14.6B | $13.1B | ||
| Q3 25 | $7.1B | $13.1B | ||
| Q2 25 | $7.1B | $13.1B | ||
| Q1 25 | $6.8B | $13.1B | ||
| Q4 24 | $6.5B | $13.1B | ||
| Q3 24 | $5.1B | $12.8B | ||
| Q2 24 | $5.0B | $12.8B |
股东权益
APH
THC
| Q1 26 | $14.1B | — | ||
| Q4 25 | $13.4B | $4.2B | ||
| Q3 25 | $12.5B | $4.0B | ||
| Q2 25 | $11.5B | $3.7B | ||
| Q1 25 | $10.3B | $4.2B | ||
| Q4 24 | $9.8B | $4.2B | ||
| Q3 24 | $9.5B | $3.8B | ||
| Q2 24 | $9.0B | $3.5B |
总资产
APH
THC
| Q1 26 | $42.1B | — | ||
| Q4 25 | $36.2B | $29.7B | ||
| Q3 25 | $27.1B | $29.4B | ||
| Q2 25 | $25.7B | $28.7B | ||
| Q1 25 | $22.9B | $29.2B | ||
| Q4 24 | $21.4B | $28.9B | ||
| Q3 24 | $19.6B | $29.4B | ||
| Q2 24 | $18.6B | $29.3B |
负债/权益比
APH
THC
| Q1 26 | 1.33× | — | ||
| Q4 25 | 1.09× | 3.10× | ||
| Q3 25 | 0.57× | 3.26× | ||
| Q2 25 | 0.62× | 3.49× | ||
| Q1 25 | 0.66× | 3.13× | ||
| Q4 24 | 0.66× | 3.14× | ||
| Q3 24 | 0.54× | 3.33× | ||
| Q2 24 | 0.56× | 3.67× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $1.1B | $731.0M |
| 自由现金流经营现金流 - 资本支出 | — | $367.0M |
| 自由现金流率自由现金流/营收 | — | 6.6% |
| 资本支出强度资本支出/营收 | 3.8% | 6.6% |
| 现金转化率经营现金流/净利润 | 1.19× | 1.14× |
| 过去12个月自由现金流最近4个季度 | — | $2.5B |
8季度趋势,按日历期对齐
经营现金流
APH
THC
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.7B | $731.0M | ||
| Q3 25 | $1.5B | $1.1B | ||
| Q2 25 | $1.4B | $936.0M | ||
| Q1 25 | $764.9M | $815.0M | ||
| Q4 24 | $847.1M | $-331.0M | ||
| Q3 24 | $704.0M | $1.0B | ||
| Q2 24 | $664.1M | $747.0M |
自由现金流
APH
THC
| Q1 26 | — | — | ||
| Q4 25 | $1.5B | $367.0M | ||
| Q3 25 | $1.2B | $778.0M | ||
| Q2 25 | $1.1B | $743.0M | ||
| Q1 25 | $576.3M | $642.0M | ||
| Q4 24 | $647.3M | $-661.0M | ||
| Q3 24 | $474.0M | $829.0M | ||
| Q2 24 | $522.8M | $602.0M |
自由现金流率
APH
THC
| Q1 26 | — | — | ||
| Q4 25 | 22.8% | 6.6% | ||
| Q3 25 | 19.6% | 14.7% | ||
| Q2 25 | 19.8% | 14.1% | ||
| Q1 25 | 12.0% | 12.3% | ||
| Q4 24 | 15.0% | -13.0% | ||
| Q3 24 | 11.7% | 16.2% | ||
| Q2 24 | 14.5% | 11.8% |
资本支出强度
APH
THC
| Q1 26 | 3.8% | — | ||
| Q4 25 | 3.9% | 6.6% | ||
| Q3 25 | 4.2% | 5.3% | ||
| Q2 25 | 5.3% | 3.7% | ||
| Q1 25 | 3.9% | 3.3% | ||
| Q4 24 | 4.6% | 6.5% | ||
| Q3 24 | 5.7% | 4.2% | ||
| Q2 24 | 3.9% | 2.8% |
现金转化率
APH
THC
| Q1 26 | 1.19× | — | ||
| Q4 25 | 1.44× | 1.14× | ||
| Q3 25 | 1.18× | 1.83× | ||
| Q2 25 | 1.30× | 1.79× | ||
| Q1 25 | 1.04× | 1.31× | ||
| Q4 24 | 1.14× | -0.58× | ||
| Q3 24 | 1.16× | 1.53× | ||
| Q2 24 | 1.27× | 1.57× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APH
| Communications Solutions | $4.5B | 60% |
| Harsh Environment Solutions | $1.7B | 22% |
| Interconnect and Sensor Systems | $1.4B | 18% |
THC
| Other | $2.9B | 52% |
| Health Care Patient Service | $1.4B | 25% |
| Equity Method Investment Nonconsolidated Investee Or Group Of Investees | $1.2B | 22% |
| Health Care Other Sources | $56.0M | 1% |